Numerous studies have linked severe stress to the development of major depressive disorder (MDD) and suicidal behaviors. Furthermore, recent preclinical studies from our laboratory and others have demonstrated that in rodents, chronic stress and the stress hormone cortisol cause oxidative damage to mitochondrial function and membrane lipids in the brain. Mitochondria play a key role in synaptic neurotransmitter signaling by providing adenosine triphosphate (ATP), mediating lipid and protein synthesis, buffering intracellular calcium, and regulating apoptotic and resilience pathways. Membrane lipids are similarly essential to central nervous system (CNS) function because cholesterol, polyunsaturated fatty acids, and sphingolipids form a lipid raft region, a special lipid region on the membrane that mediates neurotransmitter signaling through G-protein-coupled receptors and ion channels. Low serum cholesterol levels, low antioxidant capacity, and abnormal early morning cortisol levels are biomarkers consistently associated with both depression and suicidal behaviors. In this review, we summarize the manner in which nutrients can protect against oxidative damage to mitochondria and lipids in the neuronal circuits associated with cognitive and affective behaviors. These nutrients include v3 fatty acids, antioxidants (vitamin C and zinc), members of the vitamin B family (Vitamin B12 and folic acid), and magnesium. Accumulating data have shown that these nutrients can enhance neurocognitive function, and may have therapeutic benefits for depression and suicidal behaviors. A growing body of studies suggests the intriguing possibility that regular consumption of these nutrients may help prevent the onset of mood disorders and suicidal behaviors in vulnerable individuals, or significantly augment the therapeutic effect of available antidepressants. These findings have important implications for the health of both military and civilian populations.
INTRODUCTION
Chronic severe stress has been directly implicated in the pathogenesis of depression and suicidal behaviors (Robinson et al., 2009) . In United States (US) military populations, the suicide rate has been found to correlate with the frequency of deployment, suggesting that prolonged exposure to stress may play a role . Historically, suicide rates for active duty military personnel in the United States and in other industrialized countries were lower than suicide rates for the general population-usually less than half (Rothberg et al., 1990) . However, studies over the last decade have described rising suicide rates in the US military population (Lineberry, 2009 ), a finding that has lent increasing urgency to both military and civilian efforts at suicide prevention.
It has been well-established that the hypothalamicpituitary-adrenal (HPA) axis is activated during stress, with increased levels of the stress hormone cortisol. For instance, cortisol serum levels are elevated in many depressed patients, and the dexamethasone suppression test (DST) did not inhibit serum cortisol levels (Sher, 2007) . Patients with Cushing's disease, which is characterized by high cortisol levels, commonly develop depressive symptoms (Wolkowitz et al., 2001) . Altered morning cortisol levels have also been noted in individuals who attempted suicide (Sher, 2007) . Moreover, it is noteworthy that 'depression' in the sense of a low mood is a symptom of many vitamin/mineral deficiencies (e.g. Folic acid, vitamin C, magnesium) (Bourre, 2004) . Therefore, it is important to prevent depressive episodes due to vitamin/mineral deficiency, particularly for people under high levels of stress. The role of nutrients in the treatment of depression and suicidal behaviors has been extensively studied in the civilian population (Cocchi et al., 1980; Enya et al., 2004; Papakostas et al., 2005; Li and Zhang, 2007; Sowa-Kucma et al., 2008) . Whether or not the nutrients may help as a strategy for the prevention or adjunctive treatment of depression or suicidal ideation in the military and civilian population remains underexplored.
Recent preclinical and clinical studies have shown that chronic severe stress causes oxidative damage to mitochondrial function and to membrane lipids, resulting in aberrant neurotransmitter signaling and information processing in synapses and circuits mediating affective, cognitive, motoric, and neurovegetative behaviors (Shelton, 2007) . We begin this review by describing the relevant evidence linking disrupted mitochondrial function, membrane lipids, and neurotransmitter signaling with depression and suicidal behaviors. We then summarize the clinical research data demonstrating that specific nutrients that act to protect mitochondria and neurotransmitter signaling are involved in the pathogenesis and treatment of these disorders. These nutrients include v3 fatty acids, antioxidants, B family vitamins, and magnesium. Finally, we discuss the preclinical and clinical evidence that regular use of these nutrients may have preventive effects in the treatment of depression or suicidal behavior.
STRESS AND SLEEP DEPRIVATION CAUSE OXIDATIVE DAMAGE TO MITOCHONDRIAL FUNCTION AND LIPID COMPOSITION, LEADING TO IMPAIRED NEUROTRANSMITTER SIGNALING
Stress and altered HPA axis activity have been shown to increase oxidative damage and reduce antioxidant defense (McIntosh and Sapolsky, 1996; Irie et al., 2005; Epel, 2009; Wolkowitz et al., 2008) . Oxidative stress occurs when the production of oxygen-free radicals exceeds the capacity of antioxidants to neutralize them (McIntosh and Sapolsky, 1996) . After severe chronic stress, in vivo glutathione (GSH, whose decrease is an indicator for oxidative stress) were found to be depleted, suggesting a state of oxidative stress (Madrigal et al., 2001) . The study further noted that mitochondrial function was also reduced after chronic stress. Inhibiting GSH depletion by aminoguanidine (a nitric oxide synthase inhibitor) protected against the mitochondrial dysfunction induced by chronic stress (Madrigal et al., 2001 ). In addition, lipids in the brain are particularly vulnerable to oxidative stress, which has been found to induce lipid peroxidation, and leads to degradation of polyunsaturated fatty acids (PUFAs) (Virmani et al., 2005; Arts et al., 2007) . Taken together, the evidence suggests that oxidative damage induced by chronic stress may cause mitochondrial dysfunction and reduce lipid production (including PUFAs).
Accumulating research also shows that sleep deprivation is a neurobiological stressor that causes oxidative damage in the brain (McEwen, 2006; Lavie, 2009 ). Other studies demonstrated that antioxidant capacity was decreased in peripheral tissues after sleep deprivation (Everson et al., 2005) . Indeed, it has been proposed that one of the biological functions of sleep may be to protect against oxidative stress (Wolf et al., 2007) . There is extensive and well-known literature on long-term disrupted sleep cycles as a precipitant for mood disorders (WirzJustice, 2006) , and given the disrupted sleep cycle that many soldiers and trainees experience (e.g., during basic training, deployment, or military missions), this stressor may be of particular importance in military populations (van Liempt et al., 2006) .
Oxidative stress, increases in homocysteine (a neurotoxin for mitochondrial function) and glucocorticoid receptor trafficking all affect mitochondrial function during chronic stress. High ROS (superoxide, hydrogen peroxide, and hydroxyl radical) levels damage mitochondrial function (Madrigal et al., 2001; Jou et al., 2009; Sorce and Krause, 2009) . It has been shown that p66Shc is a proapoptotic protein involved in ROS production in mitochondria leading to mitochondrial damage and apoptosis under oxidative or genotoxic stress conditions such as H 2 O 2 or UV exposure. (Calabrese et al., 2010) . Moreover, in both acute and chronic stress animal models, homocysteine levels were significantly increased (Black and Garbutt, 2002; de Souza et al., 2006; Taqliari et al., 2010) . The molecular mechanism(s) for these stresses in NUTRIENTS, MITOCHONDRIAL FUNCTION, AND NEUROTRANSMITTER SIGNALLING homocysteine induced by the chronic stress remains unclear. Notably, some studies have suggested a link between high homocysteine concentrations and increased risk of depression (Almeida et al., 2004; Almeida et al., 2008) . Recent studies have similarly shown that the stress hormone corticosterone directly modulates mitochondrial function (Du et al., 2009) . While brief increases in corticosterone levels enhanced mitochondrial function, high doses or long-term administration decreased levels of the glucocorticoid receptor and neuroprotective molecule B-cell lymphoma 2 (Bcl-2) in mitochondria. Similar results were found in rats exposed to a chronic stress paradigm (Du et al., 2009) .
Mitochondria are key regulators of neurotransmitter signaling at dendrites and synapses. They mediate important and diverse cellular functions in the central nervous system (CNS), including adenosine triphosphate (ATP) production, synaptic protein expression, lipid synthesis, intracellular calcium buffering, resilience, and apoptosis (Quiroz et al., 2008, Zundorf and Reiser, 2011) . Especially in remote axons, dendrites, and synapses, mitochondria function as a 'local government' to synthesize energy ATP, lipids, and proteins; they also provide substrates for lipid synthesis, maintain calcium homeostasis, and modulate apoptotic pathways to determine resilience and atrophy (Quiroz et al., 2008; Zundorf and Reiser, 2011) . Cumulative evidence further shows that mitochondria are a key regulator of neurotransmitter signaling at the synapses (Ben-Shachar and Laifenfeld, 2004; Verstreken et al., 2005) and, in conjunction with synaptic calcium dynamics, play a very active role in regulating synaptic plasticity (Ben-Shachar and Laifenfeld, 2004; Verstreken et al., 2005; Mattson et al., 2008; Brenner-Lavie et al., 2009 ). For instance, mitochondrial transport is significantly increased in response to neuronal activity and is essential for enhancing synaptic strength (Verstreken et al., 2005; Mattson, 2007) . In support of these findings, it has been suggested that the atrophy of hippocampal dendrites and synapses seen in response to chronic stress may be due to decreased mitochondrial function (Pavlides et al., 2002; Cook and Wellman, 2004) .
Lipids are similarly particularly vulnerable to oxidative damage (Arts et al., 2007) . Sixty percent of the wet weight of the mammalian brain comprises lipids. Approximately 70% of the fatty acid pool is made de novo, and 30% must be obtained through diet. Seafood, fish oils, and fortified foods are rich sources of v-3 polyunsaturated fatty acids [v-3 PUFAs: eicosapentaenoic acid (EPA), docosapentaenoic acid (DPAv-3), and docosahexaenoic acid (DHA)], as well as cholesterol. DHA comprises 14% of total fatty acids in the body and is concentrated in neuronal membranes and synapses (Kunugi, 2001; Brunner et al., 2002) . The composition of lipids, including cholesterol and PUFAs, can be affected by both cellular function and diet. In this regard, oxidative stress has a large impact on lipid metabolism (including both cholesterol and PUFAs). Lipid peroxidation leads to oxidative lipid deterioration, which alters membrane permeability and fluidity and results in lipid degradation (Delibas et al., 2004; Engstrom et al., 2009) . Lipid peroxidation can be inhibited by antioxidants such as vitamin C and vitamin E, which protect lipids from oxidation (Mahadik et al., 2001; Frank and Gupta, 2005) . Notably, levels of malondialdehyde (MDA), which is a byproduct of polyunsaturated lipid degradation by ROS, were found to be significantly increased in depressed patients (Bilici et al., 2001; Khanzode et al., 2003a; Sarandol et al., 2007) . Furthermore, studies have demonstrated that lower serum cholesterol and DHA levels are associated with suicide attempts (Brunner et al., 2001; Brunner et al., 2002) .
The fatty acid composition of the human brain is the key to maintaining the structural and functional integrity of cellular membrane structures. Recent studies have demonstrated that one of the most important functions of cholesterol and DHA is to form lipid rafts-special, highly-ordered regions on the plasma membrane that are rich in cholesterol, DHA, and sphingolipids (Ferrer, 2009; Pani and Singh, 2009 ). Lipid rafts function to cluster receptors and proteins involved in signal transduction (e.g. G-protein subunits, adenylyl cyclase), aid in protein scaffolding, and facilitate internalization of G-proteincoupled receptors (Ferrer, 2009; Pani and Singh, 2009) . A subset of lipid rafts containing caveolin proteins (known as Caveolae) play an important role in modulating synaptic plasticity and neurite outgrowth (Ferrer, 2009; Pani and Singh, 2009) . As a major component of lipid rafts, DHA regulates dopaminergic and serotoninergic neurotransmission (Zimmer et al., 2000; Kodas et al., 2002) and signal transduction (Vaidyanathan et al., 1994) , and interacts with membrane-bound enzymes (Bourre et al., 1989) and ionic channels (Vreugdenhil et al., 1996) . Caveolae are widely expressed in the CNS in brain microvessels, endothelial cells, astrocytes, oligodendrocytes, Schwann cells, dorsal root ganglia, and hippocampal neurons (Allen et al., 2007) .
Investigators have suggested that neurotransmitter signaling may occur via clustering of receptors in lipid rafts or caveolae, and the effects of lipid rafts on neurotransmitter signaling have been implicated in neurological and psychiatric diseases in general (Nomura et al., 2008; Pani and Singh, 2009) , and in mood disorders in particular (Shiah and Yatham, 2000; Brambilla et al., 2003; Donati et al., 2008) . Traditionally, the brain systems receiving the greatest attention in neurobiological studies of mood disorders were the monoaminergic neurotransmitter systems (e.g., the serotonergic, dopaminergic, and norepinephrinergic systems) that are extensively distributed throughout the network of limbic, striatal, hippocampal, and prefrontal cortical neuronal circuits (Drevets, 2000; Manji and Duman, 2001; Nestler et al., 2002) . However, recent studies show that glutamatergic synaptic plasticity may be the convergence point for the treatment of mood disorders, and alterations in this system are known to play a major role in cellular plasticity and resilience (Sanacora et al., 2008) . Existing antidepressants and mood stabilizers have prominent effects on the glutamatergic system, and modulating glutamatergic, ionotropic, or metabotropic receptors results in antidepressant-like properties in animal models (Sanacora et al., 2008) . The structurally dissimilar mood stabilizing agents lithium and valproate were both found to reduce synaptic expression of the a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) glutamate receptor at synapses in vivo and in vitro in the hippocampus (Du et al., 2003; Du et al., 2004; Du et al., 2008) . In contrast, antidepressant agents such as imipramine, lamotrigine, and riluzole enhanced surface AMPA receptor expression and phosphorylation of GluR1S845 in the hippocampus in vivo (Du et al., 2007) . As a result, several glutamatergic modulators targeting various glutamate components are currently being studied in the treatment of mood disorders, including release inhibitors of glutamate, N-methyl-D-aspartate (NMDA) antagonists, AMPA throughput enhancers, and glutamate transporter enhancers (Sanacora et al., 2008) . Preliminary pharmacogenetic studies have also strongly implicated glutamatergic signaling in suicidal behaviors (Lekman et al., 2008) .
Taken together, these findings suggest that chronic stress damages mitochondrial function and subsequently changes the lipid composition in the brain. The altered lipid composition may have a large impact on the structural and functional integrity of the cellular membrane structure, ultimately leading to aberrant neurotransmitter signaling. This altered neurotransmitter signaling may in turn contribute to the pathophysiology of depression and suicidal behavior ( Figure 1 ).
CURRENT HYPOTHESES REGARDING THE ETIOLOGY OF DEPRESSION AND SUICIDAL BEHAVIORS
Many hypotheses for the pathophysiology of depression and suicidal behaviors have been proposed, and it is beyond the scope of this article to review them all. However, it is interesting to note the large and varied literature on depression implicates (but is not limited to) many different etiologies to varying degrees, including dysfunction or alterations in monoamine neurotransmitters (serotonin, norepinephrine, and dopamine) (Syvalahti, 1987; Bourin et al., 2002; Owens, 2004) , oxidative stress (Maes et al., 2011) , glutamatergic synaptic strength (Du et al., 2004; Du et al., 2007; Zarate and Manji, 2008) , mitochondria (Rezin et al., 2008) , cytokines (Maes et al., 2009b) , homocysteine (Folstein et al., 2007) , lipids (including cholesterol and PUFAs) (Su, 2009) , neurotrophins or growth factors (Dwivedi, 2009; Molendijk et al., 2011) , magnesium (Eby and Eby, 2010) , zinc (Irmisch et al., 2010) , cyclic AMP (cAMP) response element binding (CREB) (Czeh and Simon, 2005) , and histone deacetylase (HDAC) (Covington et al., 2009 ). Finally, stress (Bao et al., 2008) , sleep (Fang et al., 2010) , altered neurotransmitter serotonin signaling (Nordstrom and Asberg, 1992; Brown and Gershon, 1993) , lipids (Brunner et al., 2002; Colin et al., 2003) , and neurotrophins (Dwivedi, 2009 ) have all been proposed as key to the pathophysiology of suicidal behavior.
As regards the hypotheses presented in this paper, several common threads from this disparate literature emerge. For instance, accumulating evidence suggests that chronic stress and sleep deprivation increase cortisol levels (Wolkowitz et al., 2001 ), which in turn leads to oxidative stress (Madrigal et al., 2001 ) and high homocysteine levels (Black and Garbutt, 2002; de Souza et al., 2006) and, subsequently, to mitochondrial damage (Madrigal et al., 2001) and lipid degradation (Arts et al., 2007) in neuronal circuits. The lipid raft region is composed of cholesterol, polyunsaturated fatty acids (including EPA, DHA), and sphingolipids and mediates neurotransmitter signaling through G-protein-coupled receptors and ion channels (Pani and Singh, 2009) . It has been shown that depletion of cholesterol or EPA and DHA decreased the number of lipid rafts on the neuronal membrane, which may lead to aberrant G-protein-coupled receptor signaling (Siddiqui et al., 2007) . It is noteworthy that lower serum cholesterol and DHA levels are associated with suicide attempts (Neaton et al., 1992; Brunner et al., 2001; Brunner et al., 2002) . Drugs that lower cholesterol levels can cause depressive symptoms (Tatley and Savage, 2007) . In addition, intake of fish (which is rich in EPA and/or DHA) directly protects against the onset of major depressive disorder (Weidner et al., 1992) . Moreover, chronic stress inhibits the respiratory chain in brain mitochondria (Madrigal et al., 2001 ). Mitochondrial dysfunction caused by changes in biochemical cascade or the damage to the mitochondrial electron transport chain has been suggested as an important pathogenic factor for the psychiatric disorders, particularly in bipolar disorders and depression (Rezin et al., 2009) . Moreover, food supplements that protect mitochondrial function (such as B12 or folate, which protects mitochondrial functions) are effective as an adjunctive therapy for the treatment of depression (Papakostas et al., 2005) . All these studies imply that mitochondrial dysfunction and reduced formation of lipid raft may be involved in the etiology of depression and suicidal behavior ( Figure 1 ). These stress-induced neuronal dysfunctions interact with other genetic and environmental factors, including adverse childhood events, exposure to trauma, drug abuse, smoking, alcohol usage, sleep, diet, and exercise levels, to precipitate mood disorders in genetically and/or physiologically vulnerable or predisposed individuals ( Figure 1 ). The evidence reviewed here thus provides multiple targets for the treatment of mood and anxiety disorders. Below, we review evidence supporting the ability of several nutrients that are safe and widely-available over the counter to either prevent the onset of these conditions or augment the effects of currently available therapeutics. Figure 1 Stress-induced damage to mitochondrial function and neurotransmitter signaling in the pathophysiology of PTSD, depression, and suicidal ideation. Chronic stress and sleep deprivation increase cortisol (which binds to its receptor, glucocorticoid receptor, GR) and corticotrophin-releasing factor (CRF), followed by enhanced oxidative stress and higher homocysteine levels, which subsequently lead to mitochondrial dysfunction and lipid degradation in the neurons in the circuits mediating cognitive, affective, motoric, and neurovegetative functions. In addition, it was reported that chronic stress lead to downregulation of neurotrophic factor brain-derived neurotrophic factor (BDNF) expression, which may also contribute to the chronic stress-induced neuronal damage. Chronic stress also increases intracellular glutamate levels, which may cause altered calcium signaling and oxidative stress in the neurons. Glial cells include the astrocytes, oligodendrocytes, and microglia. Tripartite synapse represents the pre-synaptic structure, the post-synaptic structure and the surrounding astrocyte as a functional unit. Astrocytes sense and regulate synaptic activity depending on intracellular Ca 2C levels. Mitochondria provide trophic support, energy, and calcium-buffering capacity in the neuronal cell body, the astrocytes, the dendrites, and the synapses. Mitochondrial dysfunction and altered lipid rafts may lead to aberrant neurotransmitter signaling, dendritic atrophy, and neuronal endangerment. This stress-induced neuronal damage interacts with genetic and environmental factors, including adverse childhood events, exposure to trauma, drug abuse, smoking, alcohol use, sleep, diet, and exercise levels to eventually precipitate mental illness in vulnerable individuals. Depending on the severity of these factors, and an individual's personal predisposition, the course of the illness may develop towards a variety of psychiatric disorders.
NUTRIENTS, MITOCHONDRIAL FUNCTION, AND NEUROTRANSMITTER SIGNALLING

OXIDATIVE STRESS, CHOLESTEROL, AND v3 FATTY ACIDS IN THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION AND SUICIDAL BEHAVIORS Depression and Suicidal Ideation Are Both Accompanied by Decreased Antioxidant Levels
Antioxidants are compounds that can quench free radicals by accepting an unpaired electron. In addition to the endogenous antioxidant enzyme systems, food contains many antioxidants, including vitamin E, vitamin C, beta-carotene, leutin, a-lipoic acid, coenzyme Q10 (Co-Q10), lycopene, zeaxanthines, and selenium. Although results from large randomized trials of dietary interventions have yielded mixed results, a number of observational studies have revealed that antioxidants enhance CNS cognition and resilience, particularly in neurodegenerative and psychiatric disorders (Smith and Blumenthal, 2010) . For instance, accumulating evidence has shown that MDD is associated with decreased antioxidant levels and with the induction of oxidative pathways (Sarandol et al., 2007; Ng et al., 2008) . Other studies have noted that individuals with MDD have significantly lower plasma concentrations of a number of key antioxidants, including vitamin C, vitamin E, zinc, and Co-Q10 (Khanzode et al., 2003b; Maes et al., 2009a) . One study suggested that lowered blood concentrations of zinc, CoQ10, vitamin E, vitamin C, and GSH might contribute to a lowered total antioxidant capacity (TAC), which was noted to be significantly lower in 57 patients with MDD than in 40 healthy volunteers (Cumurcu et al., 2009) . A significant and inverse correlation was also noted between TAC and severity of depression using the Montgomery-Asberg Depression Rating Scale (MADRS) (Galecki et al., 2009 ). Lower antioxidant enzyme activity [e.g. glutathione peroxidase (GPX)], is another feature of depression (Ozcan et al., 2004) . It is interesting to note that MDA levels were found to be significantly higher in depressed patients, and may therefore serve as a biomarker for depression (Chang et al., 2009 ). Long-term stress also causes oxidative damage to DNA (Irie et al., 2005) . One of the oxidative stress modifiers of DNA is 8-dehydroxyguanisine (8-OH-dG); levels of this compound were positively associated with depressive symptoms (Irie et al., 2003) .
Although the evidence to date is preliminary, levels of antioxidants, vitamins, and carotenoids have also been found to be lower in patients with a history of suicide attempts (Li and Zhang, 2007) . Investigators have speculated that lowered antioxidant capacity may impair protection against ROS, thus damaging fatty acids (Edwards et al., 1998; Maes et al., 1999) . As noted above, PUFAs are particularly vulnerable to lipid peroxidation.
Lower v3 Fatty Acid and Serum Cholesterol Levels Are Associated with Suicide Attempts and MDD
Epidemiological studies have identified low fish (high in v-3 fatty acid) consumption as a risk factor for mortality from suicide (Hirayama, 1990; Hibbeln and Salem, 1995; Tanskanen et al., 2001; Sublette et al., 2006) . One study noted that frequent fish consumption (twice per week or more) significantly reduced the risk of depressive symptoms and of selfreported suicidal ideation (Tanskanen et al., 2001) . A 17-year follow-up study of over 250,000 Japanese subjects showed that people who ate fish daily had a lower risk of death from suicide (Hirayama 1990 ). In addition, several reports indicate that lower v3-fatty-acid levels, including lower plasma EPA, and DHA, or EPA in red blood cells, predicted greater risk of suicide attempt (Hibbeln and Salem, 1995; Huan et al., 2004; Sublette et al., 2006) . Because both cholesterol and DHA are major components of the lipid raft, it is possible that reduced cholesterol and v3-fatty-acid levels may affect the formation of lipid rafts in the CNS, and subsequently reduce neurotransmitter signaling (Czysz and Rasenick, 2013) . Notably, increased formation of lipid rafts in the membrane would facilitate serotonergic (Renner et al., 2007; Donati et al., 2008) , dopaminergic (Villar et al., 2009) , and glutamatergic (Ponce et al., 2008; Francesconi et al., 2009 ) neurotransmitter signaling; all of these play important roles in the pathophysiology and treatment of psychiatric disorders. Studies have noted that low cholesterol levels are associated with increased risk of suicide (Neaton et al., 1992) and that this association shows an inverse relationship with baseline total serum cholesterol (Lindberg et al., 1992; Lester, 2002) . Other studies found that individuals who attempted suicide had significantly lower cholesterol levels than controls (Modai et al., 1994; Takei et al., 1994; Boston et al., 1996; Kunugi et al., 1997; Maes et al., 1997a; Rabe-Jablonska and Poprawska, 2000; Sarchiapone et al., 2001; Atmaca et al., 2002; Kim et al., 2002) . A postmortem study found that the brains of violent suicide completers had a lower grey-matter cholesterol content (Lalovic et al., 2007) , and that a family history of suicidal behavior was more frequent among carriers of Smith-Lemli-Opitz syndrome, an autosomal recessive disorder characterized by abnormally low cholesterol levels (Lalovic et al., 2004) .
Similarly, many studies have reported an association between low cholesterol levels and depression (Morgan et al., 1993; Lindberg et al., 1994; Maes et al., 1994; Cadeddu et al., 1995; Olusi and Fido, 1996; Suarez, 1999) , including a large Finnish study involving over 29,000 men (Partonen et al., 1999) . Low cholesterol levels have been found to confer increased risk of MDD (Partonen et al., 1999) , and to correlate with severity of depressive symptoms in samples of elderly men (Morgan et al., 1993) , middle-aged women (Horsten et al., 1997) , and depressed patients (Rabe-Jablonska and Poprawska, 2000; Steegmans et al., 2000; Rafter, 2001) . Studying cholesterol in depression may also help identify factors that place these patients at risk for nonresponse to treatment (Sonawalla et al., 2002) . Relatedly, use of cholesterol synthesis inhibitor statins (functionally HMG-CoA reductase inhibitors), which lower serum cholesterol levels, has been associated with psychiatrically adverse reactions, particularly depression and memory loss (Tatley and Savage, 2007) .
The Role of Antioxidants and Members of the Vitamin B Family in Enhancing Cognition and Resilience, and in the Treatment of Mood Disorders
Human studies as well as animal models of depression provide evidence suggesting that oxidative damage is involved in treatment resistance and in the working mechanisms of antidepressant agents (Alpert et al., 2002 , Papakostas et al., 2004 . For instance, one recent clinical study found that N-acetyl-cysteine (NAC), a potent antioxidant that upregulates the glutathione pathway, significantly augmented the clinical efficacy of antidepressants and mood stabilizers in individuals with bipolar disorder .
Vitamin C (ascorbate) is a water-soluble vitamin that can be oxidized (dehydroascorbate). Dehydroascorbate can be recycled to ascorbate through endogenous antioxidant enzymes and glutathione. Several studies found that taking a combination of vitamin C and vitamin E supplements enhanced cognitive function in the elderly (Morris et al., 2002; Pettenuzzo et al., 2002) . Vitamin C was also associated with antidepressant effects in patients with depression, secondary to adrenocorticotropic hormone (ACTH) treatment (Cocchi et al., 1980) . It was effective as an adjunctive treatment to fluoxetine (Amr et al., 2013) , and improved mood-as assessed by the frequency of penile-vaginal intercourse (FSI)-in healthy young adults (Brody, 2002) .
Another key vitamin is folic acid, which cooperates with vitamin B12 to promote the regeneration of methionine from homocysteine. Homocysteine is toxic to mitochondrial function (Paul et al., 2004; Coppen and Bolander-Gouaille, 2005) and, as noted previously, higher homocysteine levels have been associated with depression. In addition, methionine can be converted to S-adenosylmethionine (SAMe), which is the principal methyl donor in the brain. Double-blind, clinical trials demonstrated that, when used adjunctively with standard selective serotonin reuptake inhibitors (SSRIs), SAMe had antidepressant effects in patients with MDD (Papakostas, 2009) . Studies have linked lower folic acid levels to depression in elderly women (Ramos et al 2004) , in a middle-aged community sample (Sachdev et al., 2005) , and in male smokers (Sanchez-Villegas et al., 2009). Vitamin B12 was similarly linked to depressive symptoms in women (Sanchez-Villegas et al., 2009 ). In addition, folate depletion has been linked to disturbed metabolism of serotonergic and other biogenic amines. In studies of individuals with MDD treated with fluoxetine, low folate levels were associated with delayed onset of clinical improvement (Papakostas et al., 2005) , as well as treatment resistance (Papakostas et al., 2004) . Moreover, coadministration of methylfolate, a highly absorbable form of folic acid, has been found to augment the effects of SSRIs (Godfrey et al., 1990; Coppen and Bailey, 2000; Roberts et al., 2007) Zinc is another mineral with antioxidant properties (Powell, 2000) , and accumulating data suggest a relationship between low serum zinc levels and severity of depression (Maes et al., 1997b; Siwek et al., 2010) . Zinc deficiency increases ROS, which could harm mitochondrial function (Corniola et al., 2008) . Notably, various animal studies have demonstrated that zinc has antidepressant effects either alone or as an augmentation strategy for traditional antidepressants (Nowak et al., 2003; Sowa-Kucma et al., 2008) . These effects are hypothesized to be related to zinc's anti-oxidative properties, effects on PUFA metabolism, and neurogenesis stimulation through increased gene expression of brain-derived neurotrophic factor (BDNF) (Maes et al., 1997b; Siwek et al., 2010) . A recent double-blind, placebo-controlled study of daily zinc supplementation to imipramine therapy in patients with MDD found that MADRS scores were significantly negatively correlated with serum zinc levels; furthermore, treatment-resistant patients with MDD had lower zinc concentrations than patients who were not treatment-resistant (Siwek et al., 2010) .
Finally, magnesium is key to numerous enzymatic reactions involving the formation and use of ATP in energy metabolism. In addition, it is also an NMDA receptor blocker that controls calcium entry to the neurons (Eby and Eby, 2010) . It is noteworthy that, in both animal studies and individuals with treatment-resistant MDD, the NMDA antagonist ketamine has rapid and long-lasting anti-depressant effects (Zarate et al., 2006) . Case studies have noted that both iv (Enya et al., 2004) and oral magnesium were associated with rapid resolution of depressive symptoms secondary to various disorders, including MDD (Eby and Eby, 2006) . In addition, in a double-blind randomized clinical trial, it was shown that magnesium was as effective as imipramine in treating depressive symptoms in elderly patients with Type II diabetes (Barragan-Rodriguez et al., 2008).
v3 Fatty Acids in Enhancing Cognition and Resilience and Treating Mood Disorders
One study found that increased fish intake, even combined with a cholesterol-lowering diet, decreased depressive symptoms (Weidner et al., 1992) . Diverse studies-including epidemiological studies, case-control comparisons of blood and brain tissues, double-blind, randomized, placebo-controlled trials, and meta-analyses of these trials-have consistently indicated that low fish (high in v-3 fatty acid) consumption or low v3 body compositional status increases the risk of depression and other affective illnesses (Sinclair et al., 2007) .
Both preclinical and clinical studies have shown that PUFA uptake enhances cognitive function (Richardson et al., 2003) . Both local synthesis and uptake are thought to contribute to the brain pool of DHA; in animal studies, a DHA-and cholesterol enriched diet improved spatial learning in the Morris water-maze paradigm (Hooijmans et al., 2009) . In humans, a double-blind, randomized, placebo-controlled study with one-way crossover (placebo to active treatment) reported improvements in reading, spelling, and behavior in children with developmental coordination disorder who received EPA, DHA, and g-linolenic acid supplements (Richardson et al., 2003) .
The role of v3 fatty acids in the treatment of depression has been extensive (see Table 1 for a summary). A recent metaanalysis of v3 fatty acid treatment trials in depression that included data from more than 12 independent studies (Table 1) showed that consistent therapeutic benefits were associated with adjunctive use of the v3 fatty acid EPA over placebo (Martins, 2009) . Indeed, most of the clinical trials using predominantly 1-2 g EPA/day exhibited significant beneficial effects in patients with depression (Nemets et al., 2002; Peet and Horrobin, 2002; Su et al., 2003; Hallahan et al., 2007; Jazayeri et al., 2008; Su et al., 2008a; Mischoulon et al., 2009 ). However, several clinical trials using DHA or fish oil enriched with DHA showed no beneficial effect for treating MDD or perinatal depression (Marangell et al., 2003; Silvers et al., 2005; Grenyer et al., 2007; Freeman et al., 2008; Rees et al., 2008) . The effectiveness of v3 fatty acids has also been evaluated in the treatment of bipolar depression, where two of three placebo-controlled, double-blind trials found a beneficial effect over placebo (Stoll et al., 1999; Clayton et al., 2009 ). This effect may be related to the regulation of intracellular phospholipase A2 activity (Smesny et al., 2013) . In addition, v3 fatty acid treatment was also beneficial in the treatment of schizophrenia (Peet, 2003; Nakagome et al., 2009) .
Studies have also evaluated the utility of v3 fatty acids for preventing suicidal behaviors. In a randomized, double-blind, placebo-controlled trial of patients recruited from an emergency room who had exhibited recurrent self-harm behaviors, 2 g/day of v3 long chain fatty acids led to a 45% reduction in suicidal thinking, and a 30% reduction in depressive symptoms (Hallahan et al., 2007) .
CONCLUDING REMARKS
This manuscript has summarized the existing evidence that v3 fatty acids, antioxidants, B family vitamins, zinc, and magnesium protect mitochondrial function and enhance neurotransmitter signaling in the brain. In addition, reduced v3 fatty acids, oxidative capacity, B12, and folic acid levels have been associated with both depression and suicidal ideation in humans. The question is the extent to which administration of these particular nutrients may exert beneficial effects on depressive symptoms or suicidal ideation. We have listed the components and side effects for the nutrients in Table 2 .
While this is an issue of considerable importance for public health, it has particular urgency in military populations. Numerous recent studies have called for a way to address prevention and more effective treatment strategies for depression and suicidal ideation in both civilian and military populations. There appears to be a strong relationship between duration of combat exposure and the severity of mental illness (Dohrenwend, 2006) , suggesting that the severity of stress may play a role. Specifically, repeated exposure to combat and multiple deployments might work as a repetitive severe stressor in this situation, in addition to being an "anticipatory stressor" (e.g, worrying about what will happen) as well as associated with physiological stressors (e.g., sleep deprivation) (Selby et al., 2010) . Indeed, cumulative studies have shown that exposure to combat is a risk factor for both PTSD (Lapierre, 2008) and depression (Lapierre et al., 2007) in soldiers. Not surprisingly, injured soldiers also report more depressive and suicidal problems (McAllister, 2009) . Furthermore, PTSD is strongly linked to suicidal behavior (Kessler, 2000) . As reviewed above, psychological repetitive stress, traumatic experience, and sleep deprivation were all shown to cause oxidative stress and mitochondrial damage in the brain (Zhang et al., 2006; Su et al., 2008b; Du et al., 2009; Jou et al., 2009 ). Most of the civilian clinical trials cited in this paper cover a wide age range including that of most soldiers.
The multiple nutrients reviewed here affect stress-related damage to mitochondrial function and neurotransmitter signaling at different levels in order to power a therapeutic benefit. Specifically, (1) the antioxidants vitamin C would increase oxidative status during stress, and zinc would enhance the antioxidant effect; (2) vitamin B12 and folic acid would reduce the level of the toxic homocysteine and enhance the formation of antidepressant SAMe; (3) the essential v3 fatty acids would support the function of lipid rafts; and (4) magnesium would facilitate mitochondrial enzyme function and block the calcium entry from NMDA receptors ( Figure 2 ). As noted above, previous studies have shown that antidepressant drug resistance is associated with low serum levels of folic acid (Papakostas et al., 2004) , vitamin B12 (Papakostas et al., 2004) , magnesium (Eby and Eby, 2010) , and antioxidant status (Maes et al., 2009a) . Thus, these nutrients could be of considerable utility in either preventing the onset of mood disorders and suicidal behaviors in vulnerable individuals, or significantly augmenting the therapeutic effect of available drugs. Furthermore, because these nutrients are well known to be safe and reliable, implementing their use could be an easy way to protect individuals against stress-related psychiatric disorders, including PTSD, depression, and suicide attempts. Controlled clinical trials, both preventive and therapeutic, in both civilian and military populations, are warranted.
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The authors have no conflicts of interest to disclose, financial or otherwise. Figure 2 Nutrients protect mitochondrial function and neurotransmitter signaling against stress-induced neuronal damage. Chronic stress causes increases of the cortisol level and the intracellular glutamate level in the brain. The high levels of cortisol may cause increased oxidative stress and higher homocysteine levels, which subsequently lead to mitochondrial dysfunction and lipid degradation. The intra-cellular glutamate activates the N-methyl-D-aspartic acid receptor (NMDA R) and a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPA R) and induces calcium influx, which leads to hyperactivation of the Ca 2C dependent enzymes and oxidative stress. The higher level of lipid oxidation may result in lipid degradation and lower levels of Eicosapntemacnioc Acid (EPA), Docosahexaenoic Acid (DHA), or other polyunsaturated fatty acid (PUFA) in the brain for the formation of the lipid rafts, followed by a decrease in the number of lipid rafts, which may affect the G-protein-coupled receptor signaling at the synapses. v3 fatty acids, vitamin C, folic acid, vitamin B12, zinc, and magnesium protect mitochondrial function and neurotransmitter signaling. In particular, v3 fatty acids facilitate the formation of lipid rafts, which mediate neurotransmitter signaling. Vitamin C and zinc balance stress-induced oxidative stress during chronic stress situations. Vitamin B12 and folic acid reduce homocysteine levels, and enhance the formation of S-adenosylmethionine (SAMe). Magnesium is a co-enzyme for energy production in the mitochondria. It is also an NMDA antagonist that blocks excessive calcium influx and protects neurons.
